Janiya brings a unique perspective to Tina’s Wish through her background in event planning and marketing national touring Broadway shows for three years. She graduated from Ramapo College of NJ with an MBA in Marketing and is committed to utilizing her skills to advance women’s health. She is excited to be part of Tina’s Wish and is dedicated to making a meaningful impact.
Dr. Oza has been PI and co-investigator in >150 phase I, II and III trials for gynecological cancer and advanced colorectal malignancies. Dr. Oza is Head of the Division of Medical Oncology and Hematology at Princess Margaret Cancer Centre, Co-chair of the UHN Clinical Research Collaborative Center, Past-Chair of the International Gynecologic Cancer InterGroup (GCIG), Chair of the GCIG Scientific Committee, Co-Chair of the Clinical Research Executive at UHN, and past co-chair of the National Cancer Institute Gynecologic Caner Steering Committee. Under his direction, the gynecology group is one of the largest ovarian cancer (OC) clinical trials groups consistently accruing >30% of all patients seen onto clinical trials (>200/yr) at PM. The group has participated or led seminal studies in gynecologic cancers that have led to the approval or use of targeted agents such as PARP inhibitors (olaparib, niraparib) and anti-angiogenic agents (bevacizumab) internationally.
Over the last decade, he has been PI/co-PI of 19 grants from agencies such as the Canadian Cancer Society Research Institute, Canadian Institutes for Health Research, National Institutes of Health (NIH), Ontario Institute for Cancer Research, and the US Department of Defense. Over his career he has published >315 articles (all types) including Clinical Cancer Research (IF=10), JAMA Oncology (IF=20), New England Journal of Medicine (IF=79), Lancet Oncology (IF=36) and an invited seminar to CA: A Cancer Journal for Clinicians (IF=24).
Sandra Orsulic, PhD, is a Professor of Obstetrics and Gynecology at UCLA, with a secondary appointment in Pathology and Laboratory Medicine. She earned her bachelor’s degree from the University of Zagreb, Croatia, and her Ph.D. from the University of North Carolina at Chapel Hill. Her postdoctoral training was conducted under the mentorship of Nobel Prize Laureate Dr. Harold Varmus. Prior to joining UCLA, Dr. Orsulic served as an Assistant Professor of Pathology at Harvard Medical School and Massachusetts General Hospital.
Dr. Orsulic’s research focuses on elucidating how the microenvironment contributes to cancer initiation and metastatic progression, identifying molecular markers for early cancer detection, and developing effective pre-clinical models to test targeted therapies. Her pioneering work has significantly advanced our understanding of ovarian cancer biology. Notable achievements include developing the first genetically defined mouse model of ovarian cancer and establishing syngeneic BRCA1-deficient and proficient ovarian cancer cell lines. These models have been instrumental in the pharmaceutical testing of PARP inhibitors for ovarian cancer treatment.
Since 2000, Cecelia G. Morris has served as a Judge and as a chief Judge of the United States Bankruptcy Court for the Southern District of New York. Prior to her appointment to the bench, Judge Morris was an Assistant District Attorney in Georgia and also maintained a private legal practice. Judge Morris received her BS from West Texas State University and her JD from John Marshall School of Law. Tina was one of Judge Morris’ mentors when she joined the bench showing her ‘around’ the court. Most importantly to Cecelia, Tina was a dear and trusted friend.
Michael Eisenband is Global Co-Leader of FTI Consulting’s Corporate Finance & Restructuring segment, the leader of Restructuring Services and a member of the firm’s Executive Committee. He is renowned nationally as an industry leader in providing restructuring advice to creditors and companies in complex Chapter 11 and out-of-court workout situations. Driven by results, Michael specializes in advising diverse constituencies to maximize recoveries and outcomes and brokering agreement among parties with often disparate interests. He has more than 35 years of experience in representing client interests in many of the largest and most complex restructurings and bankruptcies in history. Michael feels honored to have appeared in Judge Brozman’s courtroom as an associate with E&Y.
Kelley Cornish is a partner at Selendy Gay. Kelley joined Selendy Gay after more than 20 years as a leader of the bankruptcy practice at Paul, Weiss, Rifkind, Wharton & Garrison LLP, where she was a member of firm management. Kelley represents the full range of participants in bankruptcy cases and corporate restructurings. She also has substantial experience in complex commercial litigation, including bankruptcy-related litigation. Kelley is an industry trailblazer and is consistently recognized by Chambers, The Legal 500, Lawdragon, The Best Lawyers in America, IFLR1000 and Who’s Who Legal as a leading bankruptcy and restructuring lawyer. Kelley is known for her commitment to philanthropy and generously gives her time to multiple community organizations.
